Nanopath
Pre-clinicalNanopath has developed deep technological breakthroughs that have the potential to change the molecular diagnostic paradigm.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $13.5M
About
Nanopath has developed deep technological breakthroughs that have the potential to change the molecular diagnostic paradigm.
Diagnostics
Funding History
2Total raised:$13.5M
Series A$10MMay 15, 2023
Seed$3.5MSep 15, 2021